- Home
- TTNP vs HSDT Comparison
TTNP vs HSDT Comparison
Compare TTNP & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- HSDT
- Stock Information
- Founded
- TTNP 1991
- HSDT N/A
- Country
- TTNP United States
- HSDT United States
- Employees
- TTNP N/A
- HSDT N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TTNP Health Care
- HSDT Health Care
- Exchange
- TTNP Nasdaq
- HSDT Nasdaq
- Market Cap
- TTNP 5.4M
- HSDT 6.4M
- IPO Year
- TTNP 1996
- HSDT N/A
- Fundamental
- Price
- TTNP $4.33
- HSDT $22.33
- Analyst Decision
- TTNP
- HSDT Hold
- Analyst Count
- TTNP 0
- HSDT 1
- Target Price
- TTNP N/A
- HSDT N/A
- AVG Volume (30 Days)
- TTNP 89.3K
- HSDT 1.1M
- Earning Date
- TTNP 08-14-2025
- HSDT 11-11-2025
- Dividend Yield
- TTNP N/A
- HSDT N/A
- EPS Growth
- TTNP N/A
- HSDT N/A
- EPS
- TTNP N/A
- HSDT N/A
- Revenue
- TTNP N/A
- HSDT $295,000.00
- Revenue This Year
- TTNP N/A
- HSDT N/A
- Revenue Next Year
- TTNP N/A
- HSDT $75.13
- P/E Ratio
- TTNP N/A
- HSDT N/A
- Revenue Growth
- TTNP N/A
- HSDT N/A
- 52 Week Low
- TTNP $3.03
- HSDT $5.37
- 52 Week High
- TTNP $6.43
- HSDT $1,200.00
- Technical
- Relative Strength Index (RSI)
- TTNP 48.74
- HSDT 71.73
- Support Level
- TTNP $3.90
- HSDT N/A
- Resistance Level
- TTNP $4.55
- HSDT $8.92
- Average True Range (ATR)
- TTNP 0.37
- HSDT 0.84
- MACD
- TTNP 0.00
- HSDT 1.37
- Stochastic Oscillator
- TTNP 45.99
- HSDT 92.27
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.